CD86 and malaria: The key issue in increasing vaccine efficacy may be enhancing the expression of CD86/MHC II on antigen-presenting cells before vaccination, although whether enhancing CD86/MHC II expression can totally reverse malaria-induced immune inhibition remains to be tested.